A fight over an embattled drug discount program is intensifying on Capitol Hill, as lawmakers weigh competing proposals to ...

The breadth of the proposal suggests that many organizations will need to reassess existing policies, contractual ...

CMS Administrator Dr. Oz proposes deep cuts to the 340B drug program to lower Medicare costs. Learn how this affects ...

The 340B fights of 2026 are being waged as disputes over fairness and intent. Underneath, they are disputes over data.

Hospital drug markups are in the crosshairs as a new proposal targets 340B facilities where a $700 prostate cancer treatment ...

A clear look at the 340B program: how hospitals generate revenue from drug discounts, why it has expanded, and the growing policy debate.

It's the latest evidence of rising spending in the drug discount program as regulators attempt to tamp down on growth in 340B.

“When a program designed to deliver targeted assistance drives up system-wide costs, reform is no longer optional,” says health expert Sally Pipes. “It's necessary.” If a charity organization ...

The 340B Drug Pricing Program continues to provide critical support for covered entities, although the program is subject to ongoing scrutiny and congressional, judicial, and industry pressures.

When the 340B drug pricing program was established in 1992, Congress intended for the program to help low-income and uninsured patients with their prescription drugs. The pharmaceutical companies ...

The U.S. Department of Health and Human Services has made eliminating fraud and waste a priority, with a focus on overpayments and price transparency for hospital and physician services. The rapidly ...

Long-term 340B participation is linked to stronger financial assets, with much of the program’s recent growth flowing ...